Vivaldi Capital Management’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-10,913
| Closed | -$256K | – | 228 |
|
|
2024
Q2 | $256K | Sell |
10,913
-460
| -4% | -$10.8K | 0.07% | 183 |
|
|
2024
Q1 | $283K | Buy |
+11,373
| New | +$283K | 0.08% | 174 |
|
|
2023
Q4 | – | Sell |
-7,740
| Closed | -$216K | – | 221 |
|
|
2023
Q3 | $216K | Buy |
7,740
+911
| +13% | +$25.4K | 0.07% | 174 |
|
|
2023
Q2 | $233K | Hold |
6,829
| – | – | 0.07% | 172 |
|
|
2023
Q1 | $205K | Hold |
6,829
| – | – | 0.06% | 185 |
|
|
2022
Q4 | $206K | Sell |
6,829
-47
| -0.7% | -$1.42K | 0.05% | 227 |
|
|
2022
Q3 | $226K | Sell |
6,876
-295
| -4% | -$9.7K | 0.06% | 193 |
|
|
2022
Q2 | $226K | Hold |
7,171
| – | – | 0.06% | 191 |
|
|
2022
Q1 | $232K | Sell |
7,171
-126
| -2% | -$4.08K | 0.06% | 187 |
|
|
2021
Q4 | $447K | Sell |
7,297
-17
| -0.2% | -$1.04K | 0.1% | 130 |
|
|
2021
Q3 | $547K | Sell |
7,314
-117
| -2% | -$8.75K | 0.12% | 121 |
|
|
2021
Q2 | $611K | Sell |
7,431
-41
| -0.5% | -$3.37K | 0.12% | 123 |
|
|
2021
Q1 | $572K | Buy |
+7,472
| New | +$572K | 0.11% | 130 |
|